A Study on Efficacy and Safety of Topiramate in Treatment of Obese Subjects With Dyslipidemia
Status:
Terminated
Trial end date:
2002-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy and safety of daily topiramate versus
placebo for the treatment of obese subjects with dyslipidemia.
Phase:
Phase 3
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.